Subamniotic Hemorrhage, a Possible New Presentation of Fetal and Neonatal Alloimmune Thrombocytopenia.

Allo-antibodies Fetal and neonatal alloimmune thrombocytopenia Hematoma Human platelet antigens-5b Placenta Subamniotic

Journal

Fetal diagnosis and therapy
ISSN: 1421-9964
Titre abrégé: Fetal Diagn Ther
Pays: Switzerland
ID NLM: 9107463

Informations de publication

Date de publication:
2022
Historique:
received: 16 08 2021
accepted: 23 12 2021
pubmed: 13 1 2022
medline: 6 4 2022
entrez: 12 1 2022
Statut: ppublish

Résumé

Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a rare fetal disease in which maternal antibodies directed toward fetal human platelet antigens (HPA) are formed during pregnancy and cause fetal thrombocytopenia. The diagnosis FNAIT is suspected when a fetus or neonate presents with signs of bleeding. We describe a pregnancy complicated by a placental hematoma in the 20th week of gestation as the first manifestation of FNAIT. Further evaluation showed signs of germinal matrix hemorrhage and HPA-5b allo-antibodies. After the diagnosis, intravenous immunoglobulin was administered weekly and a healthy daughter was born at 37 weeks. Histopathological analysis revealed that the hematoma was caused by a subamniotic hemorrhage of fetal origin. A subamniotic hematoma appears to be the first manifestation of FNAIT.

Sections du résumé

BACKGROUND BACKGROUND
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is a rare fetal disease in which maternal antibodies directed toward fetal human platelet antigens (HPA) are formed during pregnancy and cause fetal thrombocytopenia. The diagnosis FNAIT is suspected when a fetus or neonate presents with signs of bleeding.
CASE METHODS
We describe a pregnancy complicated by a placental hematoma in the 20th week of gestation as the first manifestation of FNAIT. Further evaluation showed signs of germinal matrix hemorrhage and HPA-5b allo-antibodies. After the diagnosis, intravenous immunoglobulin was administered weekly and a healthy daughter was born at 37 weeks. Histopathological analysis revealed that the hematoma was caused by a subamniotic hemorrhage of fetal origin.
CONCLUSION CONCLUSIONS
A subamniotic hematoma appears to be the first manifestation of FNAIT.

Identifiants

pubmed: 35021176
pii: 000521866
doi: 10.1159/000521866
doi:

Types de publication

Case Reports

Langues

eng

Sous-ensembles de citation

IM

Pagination

60-64

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2022 The Author(s). Published by S. Karger AG, Basel.

Auteurs

Steven Giesbers (S)

Department of Gynaecology and Obstetrics, Radboud University Medical Centre, Nijmegen, The Netherlands.

Manon Bos (M)

Department of Gynaecology and Obstetrics, Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands.

Johan Bulten (J)

Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands.

Lotte van der Meeren (L)

Department of Gynaecology and Obstetrics, Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands.
Department of Pathology, University Medical Centre Utrecht, Utrecht, The Netherlands.

Joris van Drongelen (J)

Department of Gynaecology and Obstetrics, Radboud University Medical Centre, Nijmegen, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH